» Articles » PMID: 33343355

Bu-Shen-Huo-Xue Decoction Ameliorates Diabetic Nephropathy by Inhibiting Rac1/PAK1/p38MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Mice

Overview
Journal Front Pharmacol
Date 2020 Dec 21
PMID 33343355
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic nephropathy (DN), a leading cause of end-stage renal disease, is associated with high morbidity and mortality rates worldwide and the development of new drugs to treat DN is urgently required. Bu-Shen-Huo-Xue (BSHX) decoction is a traditional Chinese herbal formula, made according to traditional Chinese medicine (TCM) theory, and has been used clinically to treat DN. In the present study, we established a high-fat diet/streptozotocin-induced diabetic mouse model and treated the mice with BSHX decoction to verify its therapeutic effects . Ultraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) was applied to analyze the chemical composition and active compounds of BSHX decoction. Markers of podocyte epithelial-mesenchymal transition and the Rac1/PAK1/p38MAPK signaling pathway were evaluated to investigate the mechanism underlying function of BSHX decoction. BSHX decoction effectively alleviated diabetic symptoms, according to analysis of the renal function indicators, serum creatinine, blood urea nitrogen, serum uric acid, and urinary albumin excretion rate, as well as renal histopathology and ultrastructural pathology of DN mice. We identified 67 compounds, including 20 likely active compounds, in BSHX decoction. The podocyte markers, nephrin and podocin, were down-regulated, while the mesenchymal markers, α-SMA and FSP-1, were up-regulated in DN mouse kidney; however, the changes in these markers were reversed on treatment with BSHX decoction. GTP-Rac1 was markedly overexpressed in DN mice and its levels were significantly decreased in response to BSHX decoction. Similarly, levels of p-PAK1 and p-p38MAPK which indicate Rac1 activation, were reduced on treatment with BSHX decoction. Together, our data demonstrated that BSHX decoction ameliorated renal function and podocyte epithelial-mesenchymal transition via inhibiting Rac1/PAK1/p38MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice. Further, we generated a quality control standard and numerous potential active compounds from BSHX decoction for DN.

Citing Articles

Integrated UPLC-ESI-MS/MS, network pharmacology, and transcriptomics to reveal the material basis and mechanism of Schisandra chinensis Fruit Mixture against diabetic nephropathy.

Deng Y, Ma X, He P, Luo Z, Tian N, Dong S Front Immunol. 2025; 15:1526465.

PMID: 40046619 PMC: 11879837. DOI: 10.3389/fimmu.2024.1526465.


Chinese Medicine Combined with Adipose Tissue-Derived Mesenchymal Stem Cells: A New Promising Aspect of Integrative Medicine.

Nan N, Yang N, Liu Y, Hao H Chin J Integr Med. 2025; .

PMID: 39809966 DOI: 10.1007/s11655-025-4208-z.


Tanshinone IIA Promoted Autophagy and Inhibited Inflammation to Alleviate Podocyte Injury in Diabetic Nephropathy.

Li Y, Wu T, Li H, Liu M, Xu H Diabetes Metab Syndr Obes. 2024; 17:2709-2724.

PMID: 39072344 PMC: 11277913. DOI: 10.2147/DMSO.S464015.


"Qi Nan" agarwood restores podocyte autophagy in diabetic kidney disease by targeting EGFR signaling pathway.

Li N, Liu X, Wang H, Duan Y, Zhang Y, Zhou P Chin Med. 2024; 19(1):63.

PMID: 38654354 PMC: 11040993. DOI: 10.1186/s13020-024-00923-z.


Phytochemical Profiling and Biological Activities of Pericarps and Seeds Reveal the Controversy on "Enucleation" or "Nucleus-Retaining" of Fruits.

Zhang J, Niu P, Li M, Wang Y, Ma Y, Wang P Molecules. 2024; 29(7).

PMID: 38611753 PMC: 11012811. DOI: 10.3390/molecules29071473.


References
1.
He K, Song S, Zou Z, Feng M, Wang D, Wang Y . The Hypoglycemic and Synergistic Effect of Loganin, Morroniside, and Ursolic Acid Isolated from the Fruits of Cornus officinalis. Phytother Res. 2015; 30(2):283-91. DOI: 10.1002/ptr.5529. View

2.
Ma F, Xue P, Wang Y, Wang Y, Xue S . [Research progress of serum pharmacochemistry of traditional Chinese medicine]. Zhongguo Zhong Yao Za Zhi. 2017; 42(7):1265-1270. DOI: 10.19540/j.cnki.cjcmm.20170224.010. View

3.
Dai H, Liu Q, Liu B . Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy. J Diabetes Res. 2017; 2017:2615286. PMC: 5534294. DOI: 10.1155/2017/2615286. View

4.
Haghighatdoost F, Mortazavi Najafabadi M, Bellissimo N, Azadbakht L . Association of dietary acid load with cardiovascular disease risk factors in patients with diabetic nephropathy. Nutrition. 2015; 31(5):697-702. DOI: 10.1016/j.nut.2014.11.012. View

5.
Wang L, Wang Y, Zhang X, Yang X, Wei H, An Z . Effectiveness comparisons of traditional Chinese medicine on treating diabetic nephropathy proteinuria: A systematic review and meta-analysis. Medicine (Baltimore). 2019; 98(43):e17495. PMC: 6824702. DOI: 10.1097/MD.0000000000017495. View